BB-001

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameBB-001
Drug Alias NameId-CpG-Capsid vaccine
ClassificationVaccines
Mechanisms of ActionToll like receptor 9 agonistsImmunostimulants
TargetsToll like receptor 9
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBullet Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBullet Biotechnology Inc
Active IndicationsN/A
Inactive IndicationsLymphoma, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A